Dr. Hariharan Kuhan | Addressing Metabolic Dysfunction in Cancer Care
Dr. Kuhan joined the Care Oncology team in June 2019. He completed his undergraduate medical training at Imperial College London where he graduated with a BSc in Surgery and Anesthesia. He performed his foundation and core medical training in London, working at hospitals such as St Mary’s and St Bartholomew’s. He has gained significant experience working in Medical Oncology at centres of excellence such as St Bartholomew’s, University College London, and Royal Marsden Hospitals.
Following a research fellowship at Barts Cancer Institute where he gained laboratory experience targeting metabolic pathways in cancer stem cells and circulating tumor cells, he went on to develop translational phase 1 trials based on his pre-clinical work. He attained a clinical fellow role working in an early phase trials unit, the Sarah Cannon Research Institute UK, where he was lead sub-investigator for a variety of solid tumor trials.
Dr. Kuhan continues to play an active role in clinical research and drug development. His strong background in mainstream oncology coupled with his trials experience and research work in metabolic targeting make him an excellent fit with the existing medical team at the clinic.
During our conversation, Dr. Kuhon shares what led him to transition from conventional oncology to integrative oncology, the importance of addressing metabolic dysfunction in the body, the benefits of using off-label drugs in treating cancer, the blood markers the clinic looks at to monitor their patient’s success, and his important recommendation for someone recently diagnosed with cancer.
For more information go to careoncology.com
The Cancer Liberation Project is sponsored by thekarlfeldtcenter.com
